Ridker et al. (1997) were among the first to demonstrate the predictive role of baseline CRP levels for future myocardial infarction (MI) and stroke and using CRP lowering anti-inflammatory agents as CVD-preventive agents. The gene discussed is CRP; the disease is Stroke.